Safi Hazim J, Miller Charles C, Huynh Tam T T, Estrera Anthony L, Porat Eyal E, Winnerkvist Anders N, Allen Bradley S, Hassoun Heitham T, Moore Frederick A
Department of Cardiothoracic and Vascular Surgery, The University of Texas Health Science Center at Houston Medical School, 6410 Fannin Street, Suite 450, Houston, TX 77030, USA.
Ann Surg. 2003 Sep;238(3):372-80; discussion 380-1. doi: 10.1097/01.sla.0000086664.90571.7a.
To report the long-term results of our experience using cerebrospinal fluid drainage and distal aortic perfusion in descending thoracic and thoracoabdominal aortic repair.
Repair of thoracoabdominal and thoracic aortic aneurysm by the traditional clamp-and-go technique results in a massive ischemic insult to several major organ systems. Ten years ago, we began to use distal aortic perfusion and cerebrospinal fluid drainage (adjunct) to reduce end-organ ischemia.
Between January 1991 and February 2003, we performed 1004 thoracoabdominal or descending thoracic repairs. Adjunct was used in 741 (74%) of 1004. Multivariable data were analyzed by Cox regression. Number needed to treat was calculated as the reciprocal of the risk difference.
Immediate neurologic deficit was 18 (2.4%) of 741 with adjunct and 18 (6.8%) of 263 without (P < 0.0009). In high-risk extent II aneurysms, the numbers were 11 (6.6%) of 167 with adjunct, and 11 (29%) of 38 without. Long-term survival was improved with adjunct (P < 0.002). The long-term survival results persisted after adjustment for age, extent II aneurysm, and preoperative renal function.
Use of adjunct over a long period of time has produced favorable results; approximately 1 neurologic deficit saved for every 20 uses of adjunct overall. In extent II aneurysms, where the effect is greatest, this increases to 1 saved per 5 uses. Adjunct is also associated with long-term survival, which is consistent with mitigation of ischemic end-organ injury. These long-term results indicate that cerebrospinal fluid drainage and distal aortic perfusion are safe and effective adjunct for reducing morbidity and mortality following thoracic and thoracoabdominal aortic repair.
报告我们在降胸段和胸腹主动脉修复术中使用脑脊液引流和远端主动脉灌注的长期经验结果。
采用传统的夹闭并缝合技术修复胸腹主动脉瘤和胸主动脉瘤会对多个主要器官系统造成严重的缺血性损伤。十年前,我们开始使用远端主动脉灌注和脑脊液引流(辅助手段)来减少终末器官缺血。
在1991年1月至2003年2月期间,我们进行了1004例胸腹或降胸段修复手术。1004例中有741例(74%)使用了辅助手段。多变量数据通过Cox回归分析。治疗所需人数计算为风险差异的倒数。
使用辅助手段的741例中,立即出现神经功能缺损的有18例(2.4%),未使用辅助手段的263例中有18例(6.8%)(P<0.0009)。在高危的II型动脉瘤中,使用辅助手段的167例中有11例(6.6%),未使用的38例中有11例(29%)。辅助手段可改善长期生存率(P<0.002)。在对年龄、II型动脉瘤范围和术前肾功能进行调整后,长期生存结果依然存在。
长期使用辅助手段产生了良好的效果;总体而言,每使用20次辅助手段大约可避免1例神经功能缺损。在效果最为显著的II型动脉瘤中,这一比例增至每使用5次可避免1例。辅助手段还与长期生存相关,这与减轻缺血性终末器官损伤一致。这些长期结果表明,脑脊液引流和远端主动脉灌注是降低胸段和胸腹主动脉修复术后发病率和死亡率的安全有效的辅助手段。